中科微点-全球专利检索

  1. Login
  2. Sign Up

Search Results

43 records (took 0.023 seconds)

    Porous ureteral stent
    21.
    发明授权
    Porous ureteral stent 有权
    多孔输尿管支架

    公开(公告)号：US09173735B2

    公开(公告)日：2015-11-03

    申请号：US14282959

    申请日：2014-05-20

    Applicant: Boston Scientific Scimed, Inc.

    Inventor： Hamid Davoudi ,  Alfred P. Intoccia, Jr. ,  Jianmin Li

    IPC: A61F2/04 ,  A61M25/00 ,  A61M27/00

    CPC classification number: A61F2/82 ,  A61F2/04 ,  A61F2002/048 ,  A61F2220/0008 ,  A61F2250/0023 ,  A61F2250/0067 ,  A61M25/00 ,  A61M25/0043 ,  A61M27/008

    Abstract: In some embodiments, a stent includes an elongate member and a distal retention member. The elongate member is configured to be disposed within a ureter of a patient and has a first portion, a second portion and a plurality of beads bonded together. The plurality of beads define a plurality of spaces between the plurality of beads. The plurality of spaces are configured to allow fluid to flow from the first portion of the elongate member to the second portion of the elongate member. The distal retention member is configured to help maintain a portion of the stent within a kidney of the patient.

    Abstract translation: 在一些实施例中，支架包括细长构件和远侧保持构件。 细长构件被配置为设置在患者的输尿管内，并且具有结合在一起的第一部分，第二部分和多个珠。 多个珠在多个珠之间限定多个空间。 多个空间被配置为允许流体从细长构件的第一部分流动到细长构件的第二部分。 远端定位构件构造成帮助将支架的一部分维持在患者的肾脏内。

    Occlusion of fallopian tubes in a vertebrate subject
    22.
    发明授权
    Occlusion of fallopian tubes in a vertebrate subject 有权
    在脊椎动物受试者中输卵管阻塞

    公开(公告)号：US08905032B2

    公开(公告)日：2014-12-09

    申请号：US13737004

    申请日：2013-01-09

    Applicant: Boston Scientific Scimed, Inc.

    Inventor： Michael S. H. Chu ,  Jianmin Li ,  Hamid Davoudi

    IPC: A61F6/06 ,  A61F13/00 ,  A61F2/00 ,  A61F6/14 ,  A61M1/00 ,  A61M29/00 ,  A61M5/178 ,  A61F6/22

    CPC classification number: A61F6/225

    Abstract: According to one claim of the invention, a method for occluding a fallopian tube in a vertebrate subject is described, which comprises comprising transcervically delivering a solid blocking material into the fallopian tube. In various embodiments, a fluid sealing material is delivered along with the solid blocking material. Other claims of the invention pertain to articles of manufacture, delivery devices and kits for use in occluding the fallopian tubes of a vertebrate subject.

    Abstract translation: 根据本发明的一个权利要求，描述了一种用于在脊椎动物受试者中闭塞输卵管的方法，其包括将固体阻塞材料递送到输卵管中。 在各种实施例中，流体密封材料与固体阻挡材料一起被输送。 本发明的其它权利要求涉及用于阻塞脊椎动物对象的输卵管的制品，递送装置和试剂盒。

    Controlling resorption of bioresorbable medical implant material through dispersed responsive particles
    26.
    发明授权
    Controlling resorption of bioresorbable medical implant material through dispersed responsive particles 失效
    通过分散的响应颗粒控制生物可吸收的医用植入材料的吸收

    公开(公告)号：US08545869B2

    公开(公告)日：2013-10-01

    申请号：US13685295

    申请日：2012-11-26

    Applicant: Boston Scientific Scimed, Inc.

    Inventor： Jianmin Li ,  Samuel Baldwin ,  Timothy P. Harrah

    IPC: A61F2/02

    CPC classification number: A61L31/148 ,  A61B17/12113 ,  A61F2/0004 ,  A61F2/02 ,  A61F2/04 ,  A61F2210/0004 ,  A61F2210/009 ,  A61L27/40 ,  A61L27/58 ,  A61L29/085 ,  A61L29/148 ,  A61L29/16 ,  A61L31/10 ,  A61L31/12 ,  A61L31/16 ,  A61L2300/00

    Abstract: The resorption of a medical implant can be controlled with the use of particles embedded in a resorbable bulk material forming the implant or portion thereof. The implant can be removed from a body of a mammal by natural biological mechanisms after use. The resorption of the implant can involve swelling and/or hydrolyzing of the particles within the implant upon contact with a body fluid such that porosity and flow of fluid within the bulk material of the implant is increased. Resorption of the implant may also involve the use of particles with magnetic properties embedded within the implant such that an applied magnetic field causes the particles to vibrate within the bulk material thereby increasing the porosity and thus the flow of fluid, hence facilitating resorption of the implant. The resorption rate of the implant can be controlled by modulating swelling, hydrolysis, or movement of the embedded particles.

    Abstract translation: 可以通过使用嵌入到形成植入物或其部分的可再吸收散装材料中的颗粒来控制医用植入物的吸收。 植入物可以在使用后通过天然生物学机制从哺乳动物的身体中去除。 植入物的吸收可以包括在与体液接触时使植入物内的颗粒溶胀和/或水解，使得植入物的体积材料内的流体的孔隙率和流量增加。 植入物的再吸收还可以涉及使用具有嵌入在植入物内的磁特性的颗粒，使得所施加的磁场使得颗粒在体材料内振动，从而增加孔隙率，从而增加流体的流动，从而促进植入物的再吸收 。 植入物的吸收速率可通过调节嵌入颗粒的溶胀，水解或运动来控制。

    OCCLUSION OF FALLOPIAN TUBES IN VERTEBRATE SUBJECT
    29.
    发明申请
    OCCLUSION OF FALLOPIAN TUBES IN VERTEBRATE SUBJECT 审中-公开
    在VERTEBRATE SUBJECT中的倒角管的声称

    公开(公告)号：US20150090272A1

    公开(公告)日：2015-04-02

    申请号：US14563235

    申请日：2014-12-08

    Applicant: Boston Scientific Scimed, Inc.

    Inventor： Michale S.H. Chu ,  Jianmin Li ,  Hamid Davoudi

    IPC: A61F6/22

    CPC classification number: A61F6/225

    Abstract: According to one claim of the invention, a method for occluding a fallopian tube in a vertebrate subject is described, which comprises comprising transcervically delivering a solid blocking material into the fallopian tube. In various embodiments, a fluid sealing material is delivered along with the solid blocking material. Other claims of the invention pertain to articles of manufacture, delivery devices and kits for use in occluding the fallopian tubes of a vertebrate subject.

    Abstract translation: 根据本发明的一个权利要求，描述了一种用于在脊椎动物受试者中闭塞输卵管的方法，其包括将固体阻塞材料递送到输卵管中。 在各种实施例中，流体密封材料与固体阻挡材料一起被输送。 本发明的其它权利要求涉及用于阻塞脊椎动物对象的输卵管的制品，递送装置和试剂盒。

    URETERAL STENT WITH DRUG-RELEASING STRUCTURE
    30.
    发明申请
    URETERAL STENT WITH DRUG-RELEASING STRUCTURE 有权
    具有药物释放结构的不良反应

    公开(公告)号：US20140214175A1

    公开(公告)日：2014-07-31

    申请号：US14164316

    申请日：2014-01-27

    Applicant: BOSTON SCIENTIFIC SCIMED, INC.

    Inventor： Heidi J. Barron ,  Jianmin Li

    IPC: A61F2/04

    CPC classification number: A61F2/04 ,  A61F2002/048 ,  A61F2210/0004 ,  A61F2220/0008 ,  A61F2250/0067 ,  A61K9/0036 ,  A61K31/00 ,  A61L31/148 ,  A61L31/16 ,  A61M27/008

    Abstract: According to one aspect of the present disclosure, ureteral stents are provided that comprise an elongated stent body, at least one deployable retention structure, and at least one sleeve and/or sheet of drug-releasing material. In various embodiments, at least one sleeve and/or sheet of drug-releasing material is deployed concurrently with the deployment of at least one deployable retention structure. The ureteral stents of the present disclosure are adapted to release the urologically beneficial drug into a subject.

    Abstract translation: 根据本公开的一个方面，提供输尿管支架，其包括细长的支架主体，至少一个可展开的保持结构以及至少一个药物释放材料的套管和/或片。 在各种实施方案中，药物释放材料的至少一个套筒和/或片材与至少一个可部署的保留结构的展开同时部署。 本公开的输尿管支架适于将泌尿学有益的药物释放到受试者中。

Patent Agency Ranking